Zobrazeno 1 - 10 of 374 pro vyhledávání: '"G, Ideo"'
1
Interferon treatment of chronic hepatitis C patients with normal or near normal alanine-amino-transferase levels: might it be harmful rather than useful?
Autor: A.R. Zanetti, Giorgio Bellati, A. Bellobuono, S. Tempini, Luisa Romanò, G. Ideo
Publikováno v: International Hepatology Communications. 6:8-15
The efficacy of α-interferon (αIFN) in chronic hepatitis C (CHC) with normal or near normal alanine-amino-transferase (ALT) levels is not well known. Aim of this study was to evaluate the biochemical and virological response to αIFN therapy in CHC
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5a73e7f3c85965987cce1a28b2e05e0f
https://doi.org/10.1016/s0928-4346(96)00320-9
Zobrazit plný text záznamu
2
A randomized controlled trial of thymosin-?1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody?and hepatitis B virus DNA?positive chronic hepatitis B
Autor: Annagiulia Gramenzi, Claudio Zavaglia, Indira Rezakovic, J. S. Franzone, G Ideo, Mauro Bernardi, E Altomare, Giovanni Gasbarrini, R. Severini, Pietro Andreone, Carmela Cursaro, O Albano
Publikováno v: Hepatology. 24:774-777
It has recently been shown that thymosin-alpha1(T-alpha1), a synthetic polypeptide of thymic origin, is able to promote disease remission and inhibition of hepatitis B virus (HBV) replication in patients affected by hepatitis B e antigen (HBeAg)-posi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a851c7ee116b0ab9f3990dfb7a4cb0d1
https://doi.org/10.1002/hep.510240404
Zobrazit plný text záznamu
3
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases
Autor: M. Rota, A. Ciaccio, Luciana Scalone, Mario Strazzabosco, M. Colledan, Luca S. Belli, Giancarlo Cesana, Lorenzo G. Mantovani, Roberta Ciampichini, S. Okolicsanyi, P.A. Cortesi, G. Ideo
OBJECTIVES: To assess the relationship between the type of chronic liver diseases (CLDs), clinical severity and patients’ HRQoL. METHODS: A naturalistic, multicentre study has been conducting to identify and test quality of care indicators. Adult C
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215b9ea895ba6d457267fdffb7e61b7a
http://hdl.handle.net/10281/38039
Zobrazit plný text záznamu
4
Antibodies Developing Against a Single Recombinant Interferon Protein May Neutralize Many Other Interferon-α Subtypes
Autor: G. Bellati, C.M. Brand, L. Leadbeater, G. Ideo, F. Marotta
Publikováno v: Journal of Interferon Research. 13:121-125
Three hepatitis C patients out of 15 who received recombinant interferon-alpha 2a (rIFN-alpha 2a) therapy developed high levels of neutralizing antibody coincident with clinical relapse. On analysis, antibodies in their sera were found to also produc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e4c5b7168e7e71c7b13d8168257ab4d
https://doi.org/10.1089/jir.1993.13.121
Zobrazit plný text záznamu
5
Contents Vol. 60, 1999
Autor: Hideyuki Sakoda, Gianluigi Vendemiale, J. Grillasca, P. Pederzoli, K. Böker, Magda Newton, M. Behrend, Loránd Barthó, Ignazio Grattagliano, S. Gloger, Berthold Gerdes, Timothy Wang, Motonobu Anai, Yasushi Fukushima, N. Domingo, Torsten Pietsch, Vincenzo Palmieri, Yasushi Ohmachi, Detlef K. Bartsch, M. Toepfer, C. Crotte, Roman Korolkiewicz, MichaelA. Kamm, Koji Takeuchi, H. Lafont, Nobuyuki Matsuhashi, Takehide Ogihara, Remo Naccarato, Giuseppe Palasciano, M. Schroeder, LilianeS. Deeb, R. Salvia, V. DiFrancesco, M. Falconi, Masao Nawano, Toshihito Saitoh, Roland Moll, C. Bassi, Masafumi Kubomi, Khalil Ashkar, D. Pongratz, M. Samir Arnaout, G. Cavallini, Kouichi Inukai, Vilmos Halmai, Michael Kersting, Makoto Funaki, Annette Ramaswamy, T. Clerc, Amanda Roy, Anna Baragiotta, H. Tajiri, S. Wagner, Shinichi Kato, JanM.M. Roeloffs, Tomoichiro Asano, W. Müller-Felber, K.J. Oldhafer, Yukiko Onishi, F. Marotta, E. Fesce, P. Bovo, Yoshio Yazaki, B. Thorin, LouisM.A. Akkermans, Daniel Bastian, Emanuele Altomare, N. Sartori, Kimihito Tashima, P. Flemming, W.Rodney Burnham, M. Pasetto, H. Mix, B. Vaona, L. Frulloni, Babette Simon, E. Debono, P. Safran, G. Talamini, M.O. Reynier, M. Charbonnier, H. Lochmüller, F. Chanussot, C. Folwaczny, Kamal Bikhazi, M.P. Manns, Kentaro Sugano, László Lénárd, Juanita> Merchant, R.L. Riepl, Annarosa Floreani, Mariella Molaro, G. Ideo, Piero Portincasa, John Walsh
Publikováno v: Digestion. 60:627-629
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f4de5ff02afa0fcef5d2097b97355a96
https://doi.org/10.1159/000007718
Zobrazit plný text záznamu
6
Subject Index Vol. 60, 1999
Autor: M Newton, M. Falconi, Anna Baragiotta, J. Grillasca, Hideyuki Sakoda, Vilmos Halmai, P. Pederzoli, F. Marotta, G. Talamini, P. Bovo, Yukiko Onishi, F. Chanussot, Babette Simon, Berthold Gerdes, Motonobu Anai, D. Pongratz, LilianeS. Deeb, R. Salvia, K.J. Oldhafer, Roland Moll, Gianluigi Vendemiale, Yoshio Yazaki, Nobuyuki Matsuhashi, Giuseppe Palasciano, Michael Kersting, M.O. Reynier, M. Schroeder, Shinichi Kato, Yasushi Ohmachi, N. Domingo, Ignazio Grattagliano, M. Samir Arnaout, LouisM.A. Akkermans, Timothy Wang, Annarosa Floreani, K. Böker, Torsten Pietsch, C. Bassi, Masafumi Kubomi, Kamal Bikhazi, Remo Naccarato, MichaelA. Kamm, Khalil Ashkar, Kouichi Inukai, JanM.M. Roeloffs, Annette Ramaswamy, Kentaro Sugano, W. Müller-Felber, Yasushi Fukushima, B. Thorin, G. Cavallini, Detlef K. Bartsch, M. Charbonnier, H. Tajiri, H. Lochmüller, Makoto Funaki, T. Clerc, S. Wagner, Koji Takeuchi, H. Lafont, G. Ideo, A J Roy, E. Fesce, John Walsh, Vincenzo Palmieri, Masao Nawano, C. Crotte, Toshihito Saitoh, D. Bastian, Emanuele Altomare, M. Behrend, Loránd Barthó, N. Sartori, E. Debono, S. Gloger, P. Safran, B. Vaona, L. Frulloni, M. Toepfer, Kimihito Tashima, P. Flemming, W.Rodney Burnham, M. Pasetto, H. Mix, Piero Portincasa, László Lénárd, Juanita> Merchant, R.L. Riepl, Tomoichiro Asano, Roman Korolkiewicz, Takehide Ogihara, V. DiFrancesco, Mariella Molaro, M.P. Manns, C. Folwaczny
Publikováno v: Digestion. 60:624-626
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::845fcc7ae80ee8f9450f7acc98c22708
https://doi.org/10.1159/000007717
Zobrazit plný text záznamu
7
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards
Autor: P, Gentilini, M, Bernardi, L, Bolondi, A, Craxi, G, Gasbarrinie, G, Ideo, G, Laffi, G, La Villa, F, Salerno, E, Ventura, A, Pulazzini, L, Segantini, R G, Romanelli
Publikováno v: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 36(8)
Ascites is one of the most frequent severe complications in patients with liver cirrhosis. The treatment of this chronic disease usually requires the prolonged use of albumin, frequently continued even after patients' discharge from the hospital.Aim
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ee37d761400455823121d1e4c2b6f049
https://pubmed.ncbi.nlm.nih.gov/15334775
Zobrazit plný text záznamu
8
A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B
Autor: C, Zavaglia, R, Severini, C, Tinelli, J S, Franzone, A, Airoldi, S, Tempini, G, Bettale, G, Ideo
Publikováno v: Digestive diseases and sciences. 45(4)
No consistently effective therapy is yet available for the treatment of chronic HBsAg, anti-HBe, HBV-DNA-positive hepatitis. A multicenter trial has shown that the response rates are not significantly different when patients with anti-HBe-positive he
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3b6839b6dd185075f387bebf7c6da91c
https://pubmed.ncbi.nlm.nih.gov/10759236
Zobrazit plný text záznamu
9
Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis
Autor: F, Baudo, T M, Caimi, R, Redaelli, F, De Cataldo, G, Somaini, G F, Rondinara, A, Degasperi, G, Bellati, L S, Belli, G, Ideo, M, Morfini, G, Longo
Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia. 5(4)
A patient with severe haemophilia A underwent orthotopic liver transplantation because of changes correlated to end-stage liver cirrhosis due to hepatitis B, C and D infection. Replacement therapy was carried out for 4 days and the clinical course wa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::536216f032d4efd4a8c9d1cd635d2e63
https://pubmed.ncbi.nlm.nih.gov/10469184
Zobrazit plný text záznamu
10
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)
Autor: T, Poynard, P, Marcellin, S S, Lee, C, Niederau, G S, Minuk, G, Ideo, V, Bain, J, Heathcote, S, Zeuzem, C, Trepo, J, Albrecht
Publikováno v: Lancet (London, England). 352(9138)
Only 15-20% of patients with chronic hepatitis C achieve a sustained virological response with interferon therapy. The aim of this study was to compare the efficacy and safety of interferon alpha2b in combination with oral ribavirin with interferon a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::faeaa108bc78b93e59e635e0cae08689
https://pubmed.ncbi.nlm.nih.gov/9989747
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje